Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Additional details for each of the New Clinics and the call center will be announced in subsequent press releases. A new, dedicated call center is under construction and will enhance Novamind's network of eight clinics by improving communications with clients and referring physicians, as well as facilitating the significant increase in processing of insurance reimbursements. Novamind is making additional strategic investments in the infrastructure required to support the rapid growth in client volumes at its clinics. "Expect continued and aggressive growth as we expand Novamind's clinic network and clinical research infrastructure ahead of the FDA's anticipated approvals of MDMA and psilocybin." "We are doubling the size of our clinic network six months ahead of schedule, with the added capacity enabling us to scale to 65,000 client visits in 2021," said Yaron Conforti, CEO and Director of Novamind. Scheduled to open between July and September 2021, the New Clinics represent the initial phase of Novamind's national expansion strategy whereby the Company is replicating the successful operating track record of its current clinics in Utah, at scale, ahead of its expansion into other American states in 2021. Novamind has begun construction on three of the New Clinics and leased a fourth additional property.
The expanded capacity from the New Clinics is forecasted to increase Novamind's patient volume from 20,000 client visits recorded in 2020 to approximately 65,000 client visits anticipated in 2021, a 325% increase. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it will open four new Cedar Psychiatry clinics (the "New Clinics"), doubling its network to eight total locations. TORONTO, ON / ACCESSWIRE / / Novamind Inc. New clinics represent the first phase of Novamind's national expansion strategy
0 kommentar(er)
